HESTERBIO — Hester Biosciences Income Statement
0.000.00%
Last trade - 00:00
- IN₹21.87bn
- IN₹24.11bn
- IN₹3.05bn
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,833 | 2,143 | 2,350 | 2,661 | 3,045 |
Cost of Revenue | |||||
Gross Profit | 1,364 | 1,540 | 1,586 | 1,705 | 2,087 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,406 | 1,590 | 1,912 | 2,318 | 2,635 |
Operating Profit | 427 | 554 | 438 | 343 | 411 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 413 | 501 | 535 | 402 | 320 |
Provision for Income Taxes | |||||
Net Income After Taxes | 310 | 347 | 395 | 280 | 212 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 292 | 344 | 393 | 266 | 189 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 292 | 344 | 393 | 266 | 189 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 33.9 | 43.2 | 45.7 | 27.7 | 20.9 |
Dividends per Share |